1. Celebrities deny drug rumors as false accusations run rampant
Oct 27, 2023 · Le Sserafim's Kim also found herself entangled in drug-related rumors, with claims that her temporary suspension from group activities may have ...
Amid ongoing investigations into drug allegations against actor Lee Sun-kyun and singer G-Dragon, groundless rumors have been surfacing lately regarding other celebrities' drug use. As the rumors include well-known names such as members of BTS, Kim Chae-won from Le Sserafim and Soyeon of (G)I-DLE, concerns are heightening within the entertainment industry.
2. Chae-Yong Kim - Seoul National University College of Medicine
Missing: drug | Show results with:drug
Dive into the research topics where Chae-Yong Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
3. Public Perception Towards Drug Abuse in South Korea
Missing: yoon- | Show results with:yoon-
1. National Institute on Drug Abuse. Comorbidity: addiction and other mental illnesses. [Internet]. Available at: https://www.drugsandalcohol.ie/12727/1/NIDA_Comorbidity.pdf. Accessed February 17, 2023.
4. Agencies of LE SSERAFIM's Kim Chaewon, (G)I-DLE's Jeon Soyeon ...
Oct 26, 2023 · LE SSERAFIM's Kim Chaewon, (G)I-DLE's Jeon Soyeon, and singer-songwriter Park Sun Joo have denied drug-related rumors.
LE SSERAFIM's Kim Chaewon, (G)I-DLE's Jeon Soyeon, and singer-songwriter Park Sun Joo have denied drug-related rumors. On October 25, it was revealed that BIGBANG's G-Dragon was booked on drug charges following actor Lee Sun Gyun. Along with G-Dragon, more celebrities were also reported to be booked on drug charges, and rumors about Kim Chaewon, Jeon Soyeon, and Park Sun Joo circulated on online communities. On October 26, LE SSERAFIM's agency SOURCE MUSIC stated, The rumors about Kim Chaewon are not true at all. Kim Chaewon is recovering from the aftereffects of the flu and is scheduled to resume her activities on November 1.” Jeon Soyeon's agency Cube Entertainment and Park Sun Joo's agency also both shared, The drug rumors are groundless. Cube Entertainment added, We will take strong action against the spread of false rumors. The police also clarified, The stories about the female singers are misinformation. Source (1) (2) Top Photo Credit: Xportsnews
5. Remembering Chae Won Kim, Pioneer of Psychopharmacology in ...
Chae Won Kim published various articles for educational purposes. He reviewed treatments for various conditions, such as chronic schizophrenia, neuropathic pain ...
editorial
6. Remembering Chae Won Kim, Pioneer of Psychopharmacology in ...
Moreover, he reviewed the clinical use and side effects of antidepressants, antipsychotics, and mood stabilisers.
Junghan Lee, Young Hyeong Seol, In-Sok Yeo, Suk Kyoon An, Chan-Hyung Kim. Clin Psychopharmacol Neurosci 2024;22:551-3. https://doi.org/10.9758/cpn.24.002
7. LE SSERAFIM's Kim Chae-won's agency firmly deny drug-related ...
Oct 27, 2023 · ... Kim Chae-won's drug use: "The rumors about Kim Chae-won are not true at all!" The agency stated, "Chae-won decided to suspend activities and ...
Recently, there has been much buzz in the Korean fan community due to well-known artists like Lee Sun-kyun and G-Dragon being investigated for suspected drug usage, surprisingly, Kim Chae-won from LE SSERAFIM has been unexpectedly drawn into this issue too.
8. Aging and the Prevalence of Polypharmacy and Hyper ... - Frontiers
May 8, 2022 · ... medication use. Polypharmacy for ≥90 days decreased among both ... Copyright © 2022 Cho, Chae, Yoon and Kim. This is an open-access ...
Background: Polypharmacy has become a global health problem and is associated with adverse health outcomes in the elderly. This study evaluated the prevalenc...
9. Ung Kim - The Korean Journal of Internal Medicine
... drug-eluting stents according to on-label and off-label use: Kyu-Hwan Park, Ung ... Yong Ho Song, Chae Gi Kim, Si Dong Kim, Yoon Young Kim, Jung Yoon Choe ...
10. Yoon Chae - 2024 Baseball Roster - Amherst College Athletics
Your information, including personal information and interactions with this site, may be monitored, recorded, or collected through these tools and further used ...
Yoon Chae (3) RHP/INF
11. Neural probes with multi-drug delivery capability - RSC Publishing
Neural probes with multi-drug delivery capability. H. Shin, H. J. Lee, U. Chae, H. Kim, J. Kim, N. Choi, J. Woo, Y. Cho, C. J. Lee, E. Yoon and I. Cho, Lab ...
Multi-functional neural probes are promising platforms to conduct efficient and effective in-depth studies of brain by recording neural signals as well as modulating the signals with various stimuli. Here we present a neural probe with an embedded microfluidic channel (chemtrode) with multi-drug delivery cap
12. Trends in commonly used and potentially inappropriate ...
Jun 21, 2024 · ... drug use. Polypharmacy was defined as the concurrent use of ... LaB; 2019. Cho HJ, Chae J, Yoon SH, Kim DS. Aging and the prevalence ...
Polypharmacy is a global public health concern. This study aimed to determine the prevalence of polypharmacy and trends in the use of commonly used and potentially inappropriate medications among older Korean patients. Individuals aged ≥ 65 years who were prescribed any medication between 2014 and 2018 were selected from the Korean National Health Information Database. Joinpoint regression analyses were used to determine trends in the age-adjusted polypharmacy rates by age group. The prescription rates of the most commonly used medications and the most commonly used potentially inappropriate medications were analysed by year or age group for patients with polypharmacy using the chi-square and proportion difference tests. This study included 1,849,968 patients, 661,206 (35.7%) of whom had polypharmacy. Age-adjusted polypharmacy rates increased significantly between 2014 and 2018 (P = 0.046). Among patients with polypharmacy, the most commonly prescribed medications were aspirin (100 mg), atorvastatin, metformin, glimepiride, and rosuvastatin. The most commonly prescribed and potentially inappropriate medications were alprazolam, diazepam, amitriptyline, zolpidem, and dimenhydrinate. There was a significant decrease in the prescription rates for each of these drugs in 2018 compared with 2014 among patients with polypharmacy (all P < 0.001), whereas there was a significant increase in alprazolam prescription among patients aged ≥ 85 years when analysed by age group (P &l...
